Strides Pharma Science
Strides Pharma Science Limited, commonly referred to as Strides, is a prominent player in the global pharmaceutical industry, headquartered in Bengaluru, India. Founded in 1990, the company has established a strong presence in various operational regions, including North America, Europe, and Africa. Strides focuses on the development, manufacturing, and marketing of a diverse range of pharmaceutical products, particularly in the areas of generic medications, complex generics, and over-the-counter (OTC) products.
With a commitment to quality and innovation, Strides has achieved significant milestones, including the establishment of state-of-the-art manufacturing facilities and a robust pipeline of products. The company is recognised for its unique offerings in the injectable and oral dosage forms, positioning itself as a trusted partner in the healthcare sector. Strides Pharma Science continues to strengthen its market position through strategic collaborations and a dedication to meeting the evolving needs of patients worldwide.
-4 vs industry average
Strides Pharma Science’s score of 34 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Strides Pharma Science?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Strides Pharma Science's reported carbon emissions
In 2025, Strides Pharma Science reported total emissions of approximately 53,800,000 kg CO2e, comprising 5,376,000 kg CO2e from Scope 1, 17,099,000 kg CO2e from Scope 2, and 47,827,000 kg CO2e from Scope 3 emissions. The company has set a significant near-term target to reduce absolute total Scope 1 and Scope 2 emissions by 42% by FY2030, using FY2023 as the baseline year. Strides Pharma is also committed to formulating a long-term decarbonisation strategy aimed at contributing to the global Net Zero agenda, with a target timeframe extending to 2050 for both Scope 1 and Scope 2 emissions. This commitment reflects the company's proactive approach to addressing climate change within the pharmaceutical sector. The emissions data is not cascaded from any parent organization, indicating that Strides Pharma Science is independently reporting its emissions and climate commitments.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Strides Pharma Science’s Climate Goals (2030 & 2050)
3 goals2030
42% reduction in Scope 1
Reduction of absolute total Scope 1 and Scope 2 emissions by 42% by FY2030 compared to base year FY2023.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 3 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
9 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Strides Pharma Science’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project